Dashboard
1
With a growth in Net Profit of 24.56%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 564.96 MM
- NET SALES(HY) At CNY 1,224.95 MM has Grown at 23.56%
- ROCE(HY) Highest at 12.87%
2
With ROE of 12.17%, it has a very attractive valuation with a 1.20 Price to Book Value
3
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-35.38%
0%
-35.38%
6 Months
-15.32%
0%
-15.32%
1 Year
63.9%
0%
63.9%
2 Years
106.3%
0%
106.3%
3 Years
24.15%
0%
24.15%
4 Years
79.25%
0%
79.25%
5 Years
17.36%
0%
17.36%
Tianshui Zhongxing Bio-Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.05%
EBIT Growth (5y)
23.28%
EBIT to Interest (avg)
1.94
Debt to EBITDA (avg)
2.02
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.33
Tax Ratio
0
Dividend Payout Ratio
50.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.85%
ROE (avg)
4.17%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
1.20
EV to EBIT
12.18
EV to EBITDA
7.68
EV to Capital Employed
1.16
EV to Sales
2.45
PEG Ratio
0.04
Dividend Yield
4.04%
ROCE (Latest)
9.51%
ROE (Latest)
12.17%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
602.00
623.00
-3.37%
Operating Profit (PBDIT) excl Other Income
173.20
237.50
-27.07%
Interest
14.60
15.80
-7.59%
Exceptional Items
-3.30
4.70
-170.21%
Consolidate Net Profit
163.30
130.80
24.85%
Operating Profit Margin (Excl OI)
287.70%
212.60%
7.51%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -3.37% vs 9.78% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 24.85% vs -3.61% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,098.30
1,934.70
8.46%
Operating Profit (PBDIT) excl Other Income
583.70
414.00
40.99%
Interest
57.00
77.10
-26.07%
Exceptional Items
6.80
15.30
-55.56%
Consolidate Net Profit
334.60
126.60
164.30%
Operating Profit Margin (Excl OI)
156.50%
65.80%
9.07%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 8.46% vs 0.20% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 164.30% vs -20.68% in Dec 2024
About Tianshui Zhongxing Bio-Technology Co., Ltd. 
Tianshui Zhongxing Bio-Technology Co., Ltd.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






